Comments
Glenmark Pharmaceuticals plans to raise around $200 million (around Rs 1,341 crore) by issuing dollar denominated non-convertible unsecured bonds to repay debt.
“Glenmark Pharmaceuticals Ltd has decided to tap the international bond market and is planning to raise around $200 mn by issuing USD denominated non-convertible unsecured bonds,” the company said in a BSE filing.
It further said: “The net proceeds will be used for repaying the existing debt. These bonds are planned to be listed on the Singapore Stock Exchange in order to establish the company’s track record in the globally recognised bond market.“
Shares of Glenmark Pharmaceuticals Ltd were trading 1.04 per cent lower at Rs 843 on the BSE.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.